Transgene SA
OTC:TRGNF
Transgene SA
OTC:TRGNF
Price:
0.85
USD
Market Closed
Market Cap:
$112.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Transgene SA
OTC:TRGNF
|
FR |
|
L
|
Laboratory Corporation of America Holdings
XBER:LAB
|
US |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
Essity AB (publ)
OTC:ETTYF
|
SE |
|
H
|
Hochtief AG
OTC:HOCFF
|
DE |
|
S
|
Starbucks Corp
XBER:SRB
|
US |
|
PCB Bancorp
F:9UH
|
US |
|
Lumibird SA
F:QTL
|
FR |
|
K
|
Kangda International Environmental Company Ltd
F:27K
|
CN |
|
D
|
Daikin Industries Ltd
DUS:DKI
|
JP |
|
Horizon Gold Ltd
F:HO0
|
AU |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
Wall St Price Targets
TRGNF Price Targets Summary
Transgene SA
Transgene SA
Wall Street analysts forecast TRGNF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for TRGNF is 1.63 USD with a low forecast of 1.21 USD and a high forecast of 1.95 USD.
Lowest Forecast
Price Target
1.21
USD
42% Upside
Average Forecast
Price Target
1.63
USD
92% Upside
Highest Forecast
Price Target
1.95
USD
129% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRGNF's stock price target?
Price Target
1.63
USD
1.63
USD
According to Wall Street analysts, the average 1-year price target for TRGNF is 1.63 USD with a low forecast of 1.21 USD and a high forecast of 1.95 USD.
What is the Revenue forecast for Transgene SA?
Projected CAGR
91%
91%
Over the last 14 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 91%.
